Literature DB >> 34493492

Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.

Caoilfhionn M Connolly1, Mayan Teles2, Sarah Frey2, Brian J Boyarsky2, Jennifer L Alejo2, William A Werbel3, Jemima Albayda1, Lisa Christopher-Stine1, Jacqueline Garonzik-Wang2, Dorry L Segev4,5, Julie J Paik1.   

Abstract

Entities:  

Keywords:  COVID-19; autoimmune diseases; epidemiology; vaccination

Mesh：

Substances：

Year:  2021        PMID： 34493492     DOI： 10.1136/annrheumdis-2021-221206

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

1.  Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?

Authors:  David Baker; Amy MacDougall; Angray S Kang; Klaus Schmierer; Gavin Giovannoni; Ruth Dobson
Journal:  Clin Exp Immunol       Date:  2022-05-12       Impact factor: 4.330

2.  Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.

Authors:  Mayan Teles; Caoilfhionn M Connolly; Sarah Frey; Teresa Po-Yu Chiang; Jennifer L Alejo; Brian J Boyarsky; Ami A Shah; Jemima Albayda; Lisa Christopher-Stine; William A Werbel; Dorry L Segev; Julie J Paik
Journal:  Ann Rheum Dis       Date:  2022-01-17       Impact factor: 19.103

3.  Antibody response to SARS-CoV-2 vaccination following typical and three-dose dosing schedules in multiple sclerosis patients treated with disease modifying therapies.

Authors:  Asya I Wallach; Matthew Schiebel; Mary Ann Picone
Journal:  Mult Scler Relat Disord       Date:  2022-05-06       Impact factor: 4.808

4.  Seroconversion following COVID-19 vaccination: Can we optimize protective response in CD20-treated individuals?

Authors:  David Baker; Amy MacDougall; Angray S Kang; Klaus Schmierer; Gavin Giovannoni; Ruth Dobson
Journal:  Clin Exp Immunol       Date:  2021-11-18       Impact factor: 5.732

5.  Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series.

Authors:  Ting Zhao; Jiayan Shen; Youyang Zhu; Xiaofang Tian; Guangfen Wen; Yuanyuan Wei; Bonan Xu; Chenyang Fu; Zhaohu Xie; Yujiang Xi; Zhenmin Li; Jiangyun Peng; Yang Wu; Xiaohu Tang; Chunping Wan; Lei Pan; Zhaofu Li; Dongdong Qin
Journal:  Front Public Health       Date:  2022-04-25

6.  Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.

Authors:  Theerada Assawasaksakul; Seelwan Sathitratanacheewin; Preeyaporn Vichaiwattana; Nasamon Wanlapakorn; Yong Poovorawan; Wonngarm Kittanamongkolchai
Journal:  RMD Open       Date:  2021-12

Review 7.  Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination.

Authors:  Maryam Golshani; Jiří Hrdý
Journal:  Vaccines (Basel)       Date:  2022-02-11

8.  SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.

Authors:  Jean Liew; Milena Gianfrancesco; Carly Harrison; Zara Izadi; Stephanie Rush; Saskia Lawson-Tovey; Lindsay Jacobsohn; Clairissa Ja; Kimme L Hyrich; Laure Gossec; Anja Strangfeld; Loreto Carmona; Martin Schäfer; Elsa Frãzao-Mateus; Inita Bulina; Frances Stafford; Abdurrahman Tufan; Christine Graver; Gözde Kübra Yardımcı; Julija Zepa; Samar Al Emadi; Claire Cook; Fatemah Abutiban; Dfiza Dey; Genevieve Katigbak; Lauren Kaufman; Emily Kowalski; Marco Ulises Martínez-Martínez; Naomi J Patel; Greta Reyes-Cordero; Evelyn Salido; Ellison Smith; David Snow; Jeffrey Sparks; Leanna Wise; Suleman Bhana; Monique Gore-Massy; Rebecca Grainger; Jonathan Hausmann; Emily Sirotich; Paul Sufka; Zachary Wallace; Pedro M Machado; Philip C Robinson; Jinoos Yazdany
Journal:  RMD Open       Date:  2022-04

9.  Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses.

Authors:  Kristin Schmiedeberg; Nicolas Vuilleumier; Sabrina Pagano; Werner C Albrich; Burkhard Ludewig; Johannes von Kempis; Andrea Rubbert-Roth
Journal:  Lancet Rheumatol       Date:  2021-10-26

10.  Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre.

Authors:  Chukwuma A Chukwu; Kassir Mahmood; Safa Elmakki; Julie Gorton; Phillip A Kalra; Dimitrios Poulikakos; Rachel Middleton
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.